Suppr超能文献

在快速通道门诊环境中,在冠状动脉计算机断层血管造影术前使用伊伐布雷定和比索洛尔联合进行心率降低治疗。

Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting.

作者信息

Muster Viktoria, Wallner Markus, Schmidt Albrecht, Kapl Martin, von Lewinski Friederike, Rainer Peter, Reittner Pia, Tillich Manfred, Brader Peter, Szolar Dieter Hm, von Lewinski Dirk

机构信息

1 Department of Cardiology, Medical University Graz, Austria.

3 Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA, USA.

出版信息

J Int Med Res. 2018 Jun;46(6):2249-2257. doi: 10.1177/0300060518761302. Epub 2018 Apr 3.

Abstract

Objective This study was performed to determine whether add-on oral ivabradine in patients treated with beta blockers 1 hour before coronary computed tomographic angiography (CCTA) is effective in lowering the heart rate and thus improving CCTA quality. Methods In this single-center cohort study, the data of 294 patients referred for ambulant CCTA were retrospectively screened. Patients with an initial heart rate of ≥75 bpm (n = 112) were pretreated with either a combination of bisoprolol and ivabradine or with bisoprolol alone. Results During the scan, there was no difference in heart rate between the two groups Likewise, there was no significant difference in additionally administered intravenous bradycardic agents, the number of motion artifacts, or the radiation dose. Both drug regimens were tolerated well. Conclusion Additive oral ivabradine 1 hour before CCTA does not result in a further reduction of the heart rate. Consequently, neither movement artifacts nor radiation dose can be reduced. Therefore, pretreatment with ivabradine does not seem reasonably appropriate in an outpatient clinical setting with short patient contact.

摘要

目的 本研究旨在确定在冠状动脉计算机断层扫描血管造影(CCTA)前1小时接受β受体阻滞剂治疗的患者加用口服伊伐布雷定是否能有效降低心率,从而提高CCTA质量。方法 在这项单中心队列研究中,对294例因门诊CCTA就诊患者的数据进行回顾性筛查。初始心率≥75次/分钟的患者(n = 112),要么接受比索洛尔和伊伐布雷定联合治疗,要么仅接受比索洛尔治疗。结果 在扫描期间,两组之间的心率没有差异。同样,在额外使用的静脉缓效剂、运动伪影数量或辐射剂量方面也没有显著差异。两种药物治疗方案的耐受性都很好。结论 在CCTA前1小时加用口服伊伐布雷定不会进一步降低心率。因此,既不能减少运动伪影,也不能降低辐射剂量。所以,在患者接触时间短的门诊临床环境中,使用伊伐布雷定进行预处理似乎不太合适。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1602/6023055/4c0230bcf46c/10.1177_0300060518761302-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验